<qa>  What was the main study in the Part B: Multiple Ascending Dose study?Part B: Multiple Ascending Dose study with 3 cohorts each cohort n12 subjects, total n36 subjects. 28 day administration with AMAZ-02 for safety, PK and PD assessment. 